Nautilus Biotechnology Files 8-K on Shareholder Vote
Ticker: NAUT · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1808805
| Field | Detail |
|---|---|
| Company | Nautilus Biotechnology, INC. (NAUT) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
TL;DR
Nautilus Biotech had a shareholder vote on June 20th, filing the details today.
AI Summary
Nautilus Biotechnology, Inc. filed an 8-K on June 23, 2025, reporting on matters submitted to a vote of security holders on June 20, 2025. The company, formerly Arya Sciences Acquisition Corp III, is based in Seattle, WA, and operates in the laboratory analytical instruments sector.
Why It Matters
This filing indicates that Nautilus Biotechnology held a shareholder vote, which is a standard corporate governance event that can signal important decisions or approvals affecting the company's direction.
Risk Assessment
Risk Level: low — This is a routine corporate filing regarding a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Numbers
- 001-39434 — SEC File Number (Identifies the company's filing history with the SEC.)
- 98-1541723 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- Nautilus Biotechnology, Inc. (company) — Registrant
- June 20, 2025 (date) — Date of earliest event reported
- June 23, 2025 (date) — Date of report
- ARYA Sciences Acquisition Corp III (company) — Former company name
- Seattle, Washington (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of security holders on June 20, 2025?
The filing indicates that matters were submitted to a vote, but the specific details of these matters are not provided in the provided text excerpt.
What is the primary business of Nautilus Biotechnology, Inc.?
Nautilus Biotechnology, Inc. operates in the Laboratory Analytical Instruments sector, with SIC code 3826.
When did Nautilus Biotechnology, Inc. change its name from ARYA Sciences Acquisition Corp III?
The date of the name change from ARYA Sciences Acquisition Corp III was April 8, 2020.
Where are Nautilus Biotechnology, Inc.'s principal executive offices located?
The principal executive offices are located at 2701 Eastlake Avenue East, Seattle, Washington, 98102.
What is the filing date of this Current Report on Form 8-K?
The filing date of this Current Report on Form 8-K is June 23, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Nautilus Biotechnology, Inc. (NAUT).